[Growth hormone therapy in prepubertal children with chronic renal insufficiency]. 1995

L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
II. Detská klinika DFNsP, Bratislava.

BACKGROUND Growth retardation is a serious problem in children with chronic renal failure (CRF) despite normal endogenous growth hormone (GH) secretion. Intensive medical care and dialysis do not improve height velocity. The aim of the study was to evaluate the efficacy of GH therapy in children with growth retardation secondary to CRF. RESULTS Biosynthetic growth hormone was given to 7 prepubertal children (five boys and 2 girls, age with a range 3.5-14.5 years) with severe growth retardation and CRF during 1 year. The dosage of GH was 1 IU/kg/per week. GH was given daily, sc. The patients had a full examination every 3 months. Six children completed the study. Height velocity improved with GH therapy in 5 children. Renal function deterioration was accelerated in 2 children. The serum alkaline phosphatase concentration increased and the serum calcium concentration decreased during GH treatment in all children. Glucose, thyroid gland hormone concentration and lipid concentrations remained constant. CONCLUSIONS The study showed clearly that treatment with biosynthetic GH gave an impressive improvement of height velocity in growth retarded prepubertal children with CRF.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
February 1997, Pediatric nephrology (Berlin, Germany),
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
January 1986, Medicinski arhiv,
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
February 2015, The Eurasian journal of medicine,
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
August 1995, Journal of tropical pediatrics,
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
January 1998, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
January 1996, Kidney international. Supplement,
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
January 1997, Journal of pediatric endocrinology & metabolism : JPEM,
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
November 1993, Annals of clinical biochemistry,
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
January 1997, Nephron,
L Kost'álová, and Z Misíková, and K Furková, and J Lebl, and E Simková, and H Krásnicanová
March 1978, Archives francaises de pediatrie,
Copied contents to your clipboard!